Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 18/20 | 0.65 |
| ▸ | PPARG | P37231 | 17/20 | 0.65 |
| ▸ | PPARD | Q03181 | 12/20 | 0.65 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6543498 | 0.97 | PPARG (0.65) | PPARAPPARGPPARDFAAHCES1 | |
| SCHEMBL6543916 | 0.92 | PPARA (0.63) | PPARAPPARGPPARD | |
| SCHEMBL2469118 | 0.91 | PPARG (0.71) | PPARAPPARGPPARD | |
| SCHEMBL14583509 | 0.89 | PPARA (0.74) | PPARAPPARGPPARD | |
| SCHEMBL6544084 | 0.88 | PPARA (0.58) | PPARAPPARGPPARD | |
| SCHEMBL6544117 | 0.87 | PPARA (0.57) | PPARAPPARGPPARD | |
| SCHEMBL6543411 | 0.87 | PPARG (0.64) | PPARAPPARGPPARD | |
| SCHEMBL6543006 | 0.87 | PPARA (0.56) | PPARAPPARGPPARD | |
| SCHEMBL6542928 | 0.87 | PPARG (0.74) | PPARAPPARGPPARD | |
| SCHEMBL6543936 | 0.86 | PPARG (0.51) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1433786-A1 | Benzoxazole compound and pharmaceutical composition containing the compound | Kowa Company Ltd. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-6653334-B1 | Electively activate peroxisome proliferator activated receptors | KOWA CO., LTD. (JP) | 2003-11-25 | — | — | US | disclosed |